- Vitalie Vacaras
- Dafin F. Muresanu
- Anca-Dana Buzoianu
- Daniela Botos-Vacaras
- Cristiana Vacaras
- George Vithoulkas
- Show all authors
Open AccessPublished:April 07, 2023DOI:https://doi.org/10.1016/j.jneuroim.2023.578087
Abstract
Gut microbiota, the total microorganisms in our gastrointestinal tract, might have an implication in multiple sclerosis (MS), a demyelinating neurological disease. Our study included 50 MS patients and 21 healthy controls (HC). Twenty patients received a disease modifying therapy (DMT), interferon beta1a or teriflunomide, 19 DMT combined with homeopathy and 11 patients accepted only homeopathy.